Functional neuromodulation and novel therapeutics

Group leader

Associate Professor Susannah Tye

Principal Research Fellow
 
  +61 7 3443 2493
  Susannah Tye
  s.tye@uq.edu.au

 

 

 

Our research

The Tye lab's research focuses on understanding and treating complex neuropsychiatric disorders, particularly depression and bipolar disorder. Her work integrates basic neuroscience with clinical research to develop more precise and effective therapies for treatment‑resistant mental illness. 

The team investigates how brain circuits, neurochemistry, and cellular energy systems influence mood and behaviour. Their research centres on: 
  • Neuromodulation and brain stimulation to target dysfunctional neural circuits
  • Biomarkers to improve diagnosis, predict treatment response, and enable personalised care
  • Mechanisms of treatment resistance, including the effects of stress and inflammation
  • Brain and cellular energy metabolism in psychiatric illness, particularly depression

Research focus

The Tye lab employs an end-to-end translational approach, combining neuroscience, molecular biology, and neuroengineering to measure brain activity and neurochemistry in real time, enabling direct insights into how treatments affect neural function. 

Using this approach, the team has identified altered cellular energy dynamics in young people with depression, revealing a potential biological basis for fatigue and early disease progression. They have also shown that chronic stress and inflammation can impair the brain’s response to antidepressants, limiting recovery. 

Together, these findings highlight how systemic biology, brain function, and treatment response are closely linked, supporting the development of biomarker‑guided, personalised therapies and next‑generation neuromodulation approaches.

Latest news

Pages